Cryptic activation of an Irf8 enhancer governs cDC1 fate specification
Durai V, Bagadia P, Granja JM, Satpathy AT, Kulkarni DH, Davidson JT 4th, Wu R, Patel SJ, Iwata A, Liu TT, Huang X, Briseño CG, Grajales-Reyes GE, Wöhner M, Tagoh H, Kee BL, Newberry RD, Busslinger M, Chang HY, Murphy TL, Murphy KM.
Nature Immunology, 1 September 2019
Massively parallel single-cell chromatin landscapes of human immune cell development and intratumoral T cell exhaustion
Satpathy AT*, Granja JM*, Yost KE, Qi Y, Meschi F, McDermott GP, Olsen BN, Mumbach MR, Pierce SE, Corces MR, Shah P, Bell JC, Jhutty D, Nemec CM, Wang J, Wang L, Yin Y, Giresi PG, Chang ALS, Zheng GXY*, Greenleaf WJ*, Chang HY*. *contributed equally
Nature Biotechnology, 2 August 2019
Clonal replacement of tumor-specific T cells following PD-1 blockade
Yost KE*, Satpathy AT*, Wells DK, Qi Y, Wang C, Kageyama R, McNamara K, Granja JM, Sarin KY, Brown RA, Gupta RK, Curtis C, Bucktrout SL, Davis MM, Chang ALS*, Chang HY*. *contributed equally
Nature Medicine, 29 July 2019
HiChIRP reveals RNA-associated chromosome conformation
Mumbach MR*, Granja JG*, Flynn RA, Roake CM, Satpathy AT, Rubin AJ, Qi Y, Jiang Z, Shams S, Louie BH, Guo JK, Gennert DG, Corces MR, Khavari PA, Atianand MK, Artandi SE, Fitzgerald KA, Greenleaf WJ*, Chang HY*.
Nature Methods, 27 May 2019
A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGFα-Mediated Recruitment of Neutrophils
Janela B, Patel AA, Lau MC, Goh CC, Msallam R, Kong WT, Fehlings M, Hubert S, Lum J, Simoni Y, Malleret B, Zolezzi F, Chen J, Poidinger M, Satpathy AT, Briseno C, Wohn C, Malissen B, Murphy KM, Maini AA, Vanhoutte L, Guilliams M, Vial E, Hennequin L, Newell E, Ng LG, Musette P, Yona S, Hacini-Rachinel F, Ginhoux F.
Immunity, 16 April 2019
Interrogation of human hematopoiesis at single-cell and single-variant resolution
Ulirsch JC*, Lareau CA*, Bao EL*, Ludwig LS, Guo MH, Benner C, Satpathy AT, Salem R, Hirschhorn JN, Finucane HK, Aryee MJ, Buenrostro JD*, Sankaran VG*.
Nature Genetics, 11 March 2019
A mutation in the transcription factor Foxp3 drives T helper 2 effector function in regulatory T cells
Van Gool F, Nguyen MLT, Mumbach MR, Satpathy AT, Rosenthal WL, Giacometti S, Le DT, Liu W, Brusko TM, Anderson MS, Rudensky AY, Marson A, Chang HY, Bluestone JA.
Immunity, 19 February 2019
Pembrolizumab for advanced basal cell carcinoma: an investigator-initiated, proof-of-concept study
Chang ALS, Tran DC, Cannon JGD, Li S, Jeng M, Patel R, Van der Bokke L, Pague A, Brotherton R, Rieger KE, Satpathy AT, Yost KE, Reddy S, Sarin K, Colevas AD.
Journal of the American Academy of Dermatology, 1 February 2019
Coupled single-cell CRISPR screening and epigenomic profiling reveals causal gene regulatory networks
Rubin AJ*, Parker KR*, Satpathy AT*, Qi Y, Wu B, Ong AJ, Mumbach MR, Ji AL, Kim DS, Cho SW, Zarnegar BJ, Greenleaf WJ, Chang HY*, Khavari PA*.
Cell, 10 January 2019
The chromatin accessibility landscape of primary human cancers
Corces MR*, Granja JM*, Shams S, Louie BH, Seoane JA, Zhou W, Silva TC, Greoneveld C, Wong CK, Cho SW, Satpathy AT, Mumbach MR, Hoadley KA, Robertson AG, Sheffield NC, Felau I, Castro MAA, Berman BP, Staudt LM, Zenklusen JC, Laird PW, Curtis C, TCGA, Greenleaf WJ*, Chang HY*.
Science, 26 October 2018